Bio-cannabis product pipeline ready to be commercialized In Canada.

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

Methods to monitor and potentially modulate the systemic response to cancer, offer new avenues for early detection, personalized medicine and therapeutic modalities.

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.

The World Health Organization recommends IGRA tests in the First Edition of Essential In Vitro Diagnostics.

Lonza has announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

Available in 96- and 384-well configurations - Porvair Sciences reagent reservoirs are designed for simple integration into any automated liquid handling system.

Genevac has published a technical article that describes how its Rocket™ Evaporator has been used by the Technical University of Munich (Germany) as a sample preparation tool for extraction of active phytochemicals from the leaves of Gymnema sylvestre.

Ram Group aims to introduce revolutionary low-cost point-of-care diagnostics and healthcare monitoring devices to low-income communities.

TheraT®-induced CD8+ T cells are qualitatively differentiated from CD8+ T cells induced by other vector systems; they have a much higher capacity to kill target cells in tissues.